PubMed Central, : RMMJ Rambam Maimonides Medical Journal Rambam Health Care Campus 2014 April; 5(2): e0010. ISSN: 2076-9172Published online 2014 April 28. doi: 10.5041/RMMJ.10144.

Table 2.

Survival Outcomes Following TORS for OPSCC.

TORS Study	2-Year Disease-specific Survival	2-Year Overall Survival
Cohen et al.²⁰	25/27 (92.6%)	25/31 (80.6%)
Park et al.⁵⁶		31/32 (96%)
Cognetti et al.⁵⁸	28 (93.3%)	28 (93.3%)
Weinstein et al.⁶¹	27/30 (90%)	27/33 (82%)
Genden et al.⁶²		27 (90%)
White et al.⁶³		Primary TORS cohort (89.3%)
Moore et al.⁶⁸	63 (95.5%)	63 (95.5%)

OPSCC, oropharyngeal squamous cell carcinoma; TORS, transoral robotic surgery.

RMMJ Rambam Maimonides Medical Journal Rambam Health Care Campus 2014 April; 5(2): e0010. ISSN: 2076-9172

Published online 2014 April 28. doi: 10.5041/RMMJ.10144